📉 Dr Reddy's Laboratories Ltd (NSE: DRREDDY) shares dropped 1.0% on 2 Jun 2026, closing at ₹1277.00.
📊 Market Snapshot
| Metric | Value |
|---|---|
| Open | ₹1280.20 |
| Close | ₹1277.00 |
| High | ₹1284.70 |
| Low | ₹1264.10 |
| Change | +1.04% (₹13.28) |
| Volume | 29,40,000 |
| Market Cap | ₹106000 Cr |
| 52W High | ₹1379.70 |
| 52W Low | ₹1148.40 |
🔍 Analysis
Dr Reddy's Laboratories closed at ₹1277, down 1.04% on June 2, 2026. The drop came despite a trading volume of 29.40 lakh shares, exactly matching the 30‑day average, indicating no unusual buying or selling pressure. The price moved lower from the open of ₹1280.2 and stayed within a range of ₹1284.7 high to ₹1264.1 low, suggesting the sell‑off was driven more by sentiment than heavy volume. In the past 48 hours there was no company‑specific news, but broader market headlines highlighted a string of weak performances in unrelated sectors – rail, municipal bonds and power – which kept risk‑averse investors cautious. Dr Reddy's is currently trading about 7.5% below its 52‑week high of ₹1379.7 and roughly 11% above its 52‑week low of ₹1148.4, placing it in the upper‑mid range of its yearly band. The pharma sector did not have a reported index change today, while the Nifty 50 rose 0.43%, meaning Dr Reddy's underperformed the broader market. The lack of a volume spike suggests the move was a modest reaction to overall market risk aversion rather than a sharp shift in fundamentals. Investors should keep an eye on upcoming earnings guidance and any regulatory updates that could affect pharma pricing.
🏷️ About Dr Reddy's Laboratories Ltd
- Exchange: NSE
- Sector: Pharma
- Nifty Change: +0.43%
💡 For educational purposes only. Not financial advice.
Top comments (0)